Logotype for Tango Therapeutics Inc

Tango Therapeutics (TNGX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Tango Therapeutics Inc

Proxy filing summary

17 Apr, 2026

Voting matters and shareholder proposals

  • Election of three Class II directors: Malte Peters, M.D., Kanishka Pothula, and Mace Rothenberg, M.D., with board recommendation to vote for all nominees.

  • Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

  • Advisory vote to approve compensation of named executive officers, with board recommendation to vote for.

  • Board may consider other business that arises at the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends all director nominees for election to Class II positions.

Executive compensation and say-on-pay

  • Advisory vote on executive compensation for named executive officers is included as a proposal.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more